Plasma homocysteine, measurement and clinical application

Show simple item record

dc.contributor.advisor Warner, P.
dc.contributor.advisor Kenney, A. C.
dc.contributor.author Hill, D. M.
dc.date.accessioned 2006-06-16T15:38:51Z
dc.date.available 2006-06-16T15:38:51Z
dc.date.issued 2006-01
dc.identifier.uri http://hdl.handle.net/1826/1108
dc.description.abstract Raised plasma homocysteine (Hcy) levels have been cited as a major risk factor for several vascular disorders. Yet hyperhomocysteinaemia is easily treated through dietary intervention and vitamin supplementation. Commercial assays have facilitated routine plasma Hcy analysis. However, the problem faced by clinicians is stabilisation of Hcy in whole blood samples prior to delivery to the laboratory. Following blood collection, erythrocytes continue to produce and excrete Hcy increasing plasma concentrations by up to 10% per hour. This thesis describes the investigation of stabilising plasma Hcy in whole blood, allowing wide scale screening for hyperhomocysteinaemia. The most effective method appears to be inhibition of the enzyme responsible for Hcy production, Sadenosylhomocysteine hydrolase (SAHH), using a competitive inhibitor 3- deazaadenosine (3DA). Clinical trials were conducted on a pilot batch of evacuated blood tubes. Samples were stored in EDTA whole blood in the presence and absence of 3DA, at ambient temperatures (20 to 25ºC), and under refrigerated conditions (2 to 8ºC). Only samples that were collected into EDTA plus 3DA tubes and stored refrigerated showed stability over 72 hours (p = 0.2761). For wide scale screening, samples must be stable under ambient conditions. As the structure of SAHH is known a molecular modelling approach was adopted in an attempt to identify other potential inhibitors from screened databases. Interference of SAHH, in an immunochemical method for Hcy, was to be utilised for in vitro screening before any further clinical trials were conducted. The thesis also focuses on Hcy as a marker of vitamin deficiency and explores links between thiol metabolism and the development of cognitive decline eventually leading to dementia. Disruption of single carbon metabolism can lead to an increase in Hcy and a decrease in available methyl groups important in regulation of several metabolic pathways. Increased oxidative stress may also be a causative factor. en
dc.format.extent 38700989 bytes
dc.format.mimetype application/pdf
dc.language.iso en en
dc.publisher Cranfield University
dc.rights ©Cranfield University, 2005. All rights reserved. No part of this publication may be reproduced without the written permission of the copyright holder. en
dc.title Plasma homocysteine, measurement and clinical application en
dc.type Thesis or dissertation en
dc.type.qualificationlevel Doctoral en
dc.type.qualificationname PhD en
dc.publisher.department Cranfield University at Silsoe en


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search CERES


Browse

My Account

Statistics